View Older Stories View More Recent Stories

Jul 1, 2025 07:29AM Goldman rolls out latest U.S. Conviction List update
Jun 26, 2025 07:15AM Alnylam Pharmaceuticals (ALNY) PT Raised to $377 at Needham
Jun 24, 2025 05:15AM Alnylam Pharmaceuticals (ALNY) PT Raised to $360 at BMO Capital
Jun 18, 2025 10:05AM Alnylam Pharma (ALNY) names Pushkal Garg as Chief Research and Development Officer
Jun 13, 2025 08:58AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'Amvuttra Survey Suggests 2Q Beat'
Jun 11, 2025 07:01AM Instil Bio Inc. (TIL) Appoints John Maraganore to its Board
Jun 9, 2025 06:00AM Alnylam Pharma (ALNY) Receives EU Approval for AMVUTTRA
Jun 3, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
May 30, 2025 09:29AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'HQ Visit Makes Us More Positive About The Q'
May 29, 2025 01:19PM JPMorgan Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)
May 14, 2025 09:32AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
May 12, 2025 07:01AM Alnylam Pharma (ALNY) to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study
May 6, 2025 07:13AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
May 1, 2025 08:01AM Alnylam Pharma (ALNY) Tops Q1 EPS by 92c
Apr 28, 2025 08:00AM Alnylam Pharma (ALNY) Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'
Apr 4, 2025 06:46AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Apr 3, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Mar 31, 2025 08:09AM Stifel Raises Price Target on Alnylam Pharmaceuticals (ALNY) to $345
Mar 31, 2025 06:52AM Alnylam Pharmaceuticals (ALNY) PT Raised to $342 at Scotiabank
Mar 31, 2025 05:21AM Alnylam Pharmaceuticals (ALNY) PT Raised to $345 at Stifel
Mar 31, 2025 04:16AM Redburn-Atlantic Starts Alnylam Pharmaceuticals (ALNY) at Buy
Mar 28, 2025 04:45PM Alnylam Pharma (ALNY) Announces FDA Approval of Qfitlia
Mar 27, 2025 09:14AM Bernstein on Alnylam Pharmaceuticals (ALNY): 'A Strident but Unconvincing Bear Case'
Mar 24, 2025 08:58AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'Incrementally More Positive on ALNY and Remain Buyers'
Mar 24, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Mar 24, 2025 02:03AM JPMorgan Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight
Mar 21, 2025 03:30PM Alnylam Pharma (ALNY) call put ratio 1.9 calls to 1 put on 7500 contracts as share price up 10%
Mar 21, 2025 07:44AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Mar 21, 2025 06:56AM Alnylam Pharmaceuticals (ALNY) PT Raised to $338 at Scotiabank
Mar 21, 2025 06:47AM Cantor Fitzgerald Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Mar 21, 2025 06:46AM Alnylam Pharmaceuticals (ALNY) PT Raised to $390 at Canaccord Genuity
Mar 20, 2025 05:57PM Alnylam Pharma (ALNY) announces FDA approval of AMVUTTRA
Mar 20, 2025 03:40PM Alnylam Pharma (ALNY) Halted, News Pending
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 5, 2025 07:03AM Alnylam Pharma (ALNY) Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry Luminary
Mar 3, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Feb 26, 2025 09:35AM RBC on Alnylam Pharmaceuticals (ALNY): 'We Would Be Buyers Ahead Of Upcoming PDUFA Date'
Feb 26, 2025 08:10AM Piper Sandler Reiterates Overweight on Alnylam Pharmaceuticals (ALNY), 'Confident in AMVUTTRA Approval'
Feb 25, 2025 06:45AM Alnylam Pharmaceuticals (ALNY) PT Raised to $500 at H.C. Wainwright
Feb 18, 2025 06:50AM Alnylam Pharmaceuticals (ALNY) PT Raised to $385 at Canaccord Genuity
Feb 13, 2025 08:03AM Alnylam Pharma (ALNY) Tops Q4 EPS by 64c ; Offers Guidance
Feb 11, 2025 08:18AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'Our Expert Sees A Favorable Set-up'
Feb 3, 2025 05:11AM Goldman Makes Monthly Adjustment to Director's Cut Conviction List
Jan 14, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jan 13, 2025 12:21PM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) After a Solid TTR Beat
Jan 13, 2025 11:20AM Alnylam Pharma (ALNY) Announces Preliminary Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance
Dec 22, 2024 04:00AM Barclays shares outlook for Biotech in 2025, names preferred stocks
View More Recent Stories View Older Stories